RareResearch.AI
← Back to atlas

T455M

Category 4 — Stable Fold, Function DisruptedUncertain significanceTransmembrane · predictedSource card
ThreonineMethionine at position 455 · Cytoplasmic loop 3 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type T455 — hydrogen bond to E452
Fullscreen ↗
DynaMut2 mutant · T455M
Mutant M455 — hydrogen bond to A451 lost (2 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

2 lost3 gained10 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondA451A451Preserved
Hydrogen bondE452E452Preserved
Hydrogen bondL459L459Preserved
Polar contactL447Gained
Polar contactA451A451Preserved
Polar contactE452E452Preserved
Polar contactA458A458Preserved
Polar contactL459L459Preserved
Van der WaalsE452E452Preserved
HydrophobicY444Gained
HydrophobicL447L447Preserved
HydrophobicA451Lost
HydrophobicE452Gained
HydrophobicM518Lost
HydrophobicY534Y534Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
1.21kcal/mol
Stabilising — moderate
AlphaMissense
0.467
ambiguous
AlphaFold pLDDT
84
model confidence
Schema
Cat 4
Category 4 — Stable Fold, Function Disrupted

Clinical Evidence

ClinVar classificationUncertain significance
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsWolfram syndrome 1; Cataract 41; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome
Population frequency (gnomAD v4)Ultra-rare · AF 0.0051%
cDNA changec.1364C>T
ClinVar accessionVCV001383458
Last evaluated2025/07/11 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — T455M Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Threonine → Methionine at position 455. Cytoplasmic loop 3. ClinVar Uncertain significance, AlphaMissense 0.467, DynaMut2 ΔΔG +1.21 kcal/mol (stabilising).


Identity

FieldValue
VariantT455M (p.Threonine455Methionine)
DNA changec.1364C>T
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV001383458
Amino acid changeThreonine (T) → Methionine (M)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 45583.62 — well-folded
DomainCytoplasmic loop 3
Position contextLoop region · position 455 sits between transmembrane segments, solvent-accessible
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 455 sits in a connecting loop between transmembrane helices. Loop residues are typically solvent-exposed and often contribute to interhelical contacts or serve as recognition sites for binding partners. The wild-type residue is small polar (threonine — hydroxyl); the mutant is hydrophobic sulfur (methionine). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.4673
am_classambiguous
InterpretationLikely benign (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)1.21 (Stabilising)
Job ID178094722116
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/178094722116

Clinical Evidence

FieldValue
ClassificationUncertain significance
Review statuscriteria provided, multiple submitters, no conflicts
Last evaluated2025/07/11 00:00
InheritanceAutosomal dominant pattern indicated by associated DFNA6/14/38 (WFS1 hearing loss 6).
WFS1 variant landscapeT455M is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)
  • Wolfram syndrome 1
  • Cataract 41
  • Autosomal dominant nonsyndromic hearing loss 6
  • Type 2 diabetes mellitus
  • Wolfram-like syndrome

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 4 — Stable Fold, Function Disrupted

<strong>Category 4 — Stable Fold, Function Disrupted</strong><br/><br/>|ΔΔG|=1.21 negligible. Likely site-specific functional disruption — docking strategy.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=1.21 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.467. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • T455M_molstar_viewer.html — interactive 3D viewer (auto-highlights position 455 with ball-and-stick + neighbors within 5Å)
  • T455M_variant_card.md — this card (source of truth)
  • T455M_variant_card.html — styled printable card
  • T455M_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • T455M_wildtype_interactions.pse / T455M_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the T455M PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download T455M PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.